Last updated on August 2019

A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Neovascular Age-Related Macular Degeneration (LUCERNE)


Brief description of study

This study will evaluate the efficacy, safety, durability, and pharmacokinetics of faricimab administered at intervals as specified in the protocol, compared with aflibercept once every 8 weeks (Q8W), in participants with neovascular age-related macular degeneration (nAMD).

 

Clinical Study Identifier: TX227899

Find a site near you

Start Over

University of South Florida-Morsani College of Medicine

13330 USF Laurel Dr. Tampa, FL United States
  Connect »